Cancer chronotherapy: principles, applications, and perspectives.
about
Circadian systems biology: When time mattersDeregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studiesAre We Ready to Assess Circadian Phase at Home?Tumor growth rate determines the timing of optimal chronomodulated treatment schedulesCircadian Rhythm Disruption in Cancer BiologyClinical Aspects of Human Circadian RhythmsMammalian circadian biology: elucidating genome-wide levels of temporal organizationSequential release of nanoparticle payloads from ultrasonically burstable capsules.Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapyTime for chronotherapy? Clock genes dictate sensitivity to cyclophosphamide.The clinical applications of a systems approach.Circadian phase resetting via single and multiple control targets.Novel/conceptual floating pulsatile system using high internal phase emulsion based porous material intended for chronotherapyComparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection.Healthy clocks, healthy body, healthy mindCircadian rhythm and its role in malignancySirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer.The daily rhythms of genes, cells and organs. Biological clocks and circadian timing in cellsBiological clocks and the practice of psychiatry.Mechanism-based modeling of complex biomedical systems.Carcinogenic effects of circadian disruption: an epigenetic viewpoint.Chronotherapy using corticosteroids for multiple sclerosis relapses.Chronopharmacology and controlled drug release.Circadian function in patients with advanced non-small-cell lung cancer.Emerging evidence for the interrelationship of xenobiotic exposure and circadian rhythms: a review.Dynamics of biological systems: role of systems biology in medical research.Cancer chronomics I. Origins of timed cancer treatment: early marker rhythm-guided individualized chronochemotherapy.Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.Seasonal and sex variation of high-sensitivity C-reactive protein in healthy adults: a longitudinal study.Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms.Making circadian cancer therapy practical.Circadian Rhythm Influences the Promoting Role of Pulsed Electromagnetic Fields on Sciatic Nerve Regeneration in RatsLiver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review.The circadian timing system in clinical oncology.Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer.Precise periodic components estimation for chronobiological signals through Bayesian Inference with sparsity enforcing prior.A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971.Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase.Temporal regulation of the human immune system.Circadian disruption in experimental cancer processes.
P2860
Q26796457-C2DA7BCC-4614-4F93-AC2B-A725160CB2E0Q27011441-B0D4A3D9-F869-412A-8849-EF00BE836C59Q28394264-2F481D12-EC57-4925-A9E5-037B9114FC04Q28473259-904DAD12-F317-4E99-AC05-9E81C7881AE5Q28972554-77FB5C49-1B84-4961-80BF-C2658DF9BB6CQ29031212-15EAF2A7-C009-4D84-9C85-C0096F5AB4B7Q29619081-D70726FF-1FCE-450A-B7C4-621BC3906156Q30366620-A4ED4632-5E24-49EA-9068-EE64D40014FFQ30421156-BA5F1529-24FA-4BFF-BCC1-AB962AA04CC3Q30436081-3E41BFB3-AC63-4F85-B354-EB4C28D73E5DQ33242858-863FBA26-0D54-453C-84DD-F5D56985F0DFQ33369860-4D9946F8-7F29-49A7-B92D-77ADEEFD04E5Q33563566-1EA3E242-0C4D-4CC5-8D14-23D8538C6EEBQ33582645-FA24C89C-0BFD-47D0-9B4F-7C9003AE3B90Q33598574-8B602C21-EE57-416B-9C7C-DBA03E58C645Q33784815-38BCA560-C870-457E-AC60-3354D0119478Q34168873-494FB24A-E99F-4301-A3D6-488AE3AB5FFEQ34360886-9C905201-2B8D-4F30-A915-325311E65ABBQ35454652-A6A3532F-5A16-4F10-8169-760136F1525EQ36055581-8B97EE36-FA5E-45E0-ACB3-9F911EACB307Q36121128-42E43328-1456-4538-9F86-1CF2C7DF0846Q36227089-733103D2-C531-46A9-AB8B-49E457347FEAQ36316867-12D79B4C-CB8C-4EFB-9372-D51400485521Q36614977-466D3432-765A-488B-BE2B-DE95CDF6CF15Q36659876-4A8827EA-2373-4ED0-9F89-5B1837C58377Q36670951-1CDF9FC3-0ED8-4358-96C5-3F5A02B69378Q36969364-6CFCCE67-1EA0-40F4-AB6B-AE4098952C7DQ37141085-27DC462F-6782-4E44-8116-5D89A9FCC871Q37252436-08DB3AB6-68BB-44BE-B286-F0F46F23C278Q37635574-0DC9E438-7D09-4BD4-B70F-2A82E332A4ECQ37665041-AFC37FEA-E255-4DC4-BC89-831F10FB0089Q37699585-5BA61D2A-6A81-403B-8699-9D49BEEB12D9Q37904901-55B01DBA-D1DE-4598-B7AF-406513747CE4Q38219193-5FD02B5E-6A4A-43D2-BF6F-35B0A47F84A2Q38864988-A8AB02BB-5274-4712-A8F8-166368978C28Q40033720-564B94F1-3FF4-4A99-B1D3-8BFD09D29E98Q40049440-4BCD19B0-930B-4187-8AE5-000AF22C10B5Q42926839-D6AC5C27-E4C0-45ED-A603-588960A98035Q43061706-26053F77-9DEF-4A76-B781-751BF214615EQ43204662-C93CFB0C-8E60-437F-A80C-F4A3CDFB7AA8
P2860
Cancer chronotherapy: principles, applications, and perspectives.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cancer chronotherapy: principles, applications, and perspectives.
@ast
Cancer chronotherapy: principles, applications, and perspectives.
@en
type
label
Cancer chronotherapy: principles, applications, and perspectives.
@ast
Cancer chronotherapy: principles, applications, and perspectives.
@en
prefLabel
Cancer chronotherapy: principles, applications, and perspectives.
@ast
Cancer chronotherapy: principles, applications, and perspectives.
@en
P356
P1433
P1476
Cancer chronotherapy: principles, applications, and perspectives.
@en
P2093
Francis Levi
Marie-Christine Mormont
P304
P356
10.1002/CNCR.11040
P407
P577
2003-01-01T00:00:00Z